The University of Michigan Comprehensive Cancer Center (UMCCC) requests renewal of its core grant in support of senior leadership, programs and shared facilities. The Cancer Center was established by the Board of Regents in 1989 to provide a focus for all cancer related activities throughout the University. A core grant to support the UMCCC was initially awarded by the NCI in 1988 and renewed for 5 years in 1991. The Center provides an organizational framework to promote interdisciplinary research through the development of defined clinical, basic science and prevention programs in cancer research, and the development and support of shared resources. There are ten clinical research programs including eight representing coordinated research efforts of cancers of major organ systems: breast, prostate, thorax, brain, gastrointestinal tract, cutaneous leukemia/lymphoma and pediatric tumors. In addition, there are programs in radiation oncology research and radiopharmaceuticals development. The five basic science research programs of the Center included molecular oncology, tumor metastasis and extracellular matrix, tumor immunology, cancer pharmacology, and drug discovery and development. The Center proposes two new programs in carcinogenesis and cancer prevention. Support is requested for 11 shared core facilities, including clinical trials, biostatistics, tissue procurement, tumor imaging, molecular biology and protein chemistry, morphology, flow cytometry, experimental radiation, animal facility, transgenic mouse and vector cores. The Cancer Center senior leadership is composed of the director and five associate directors, including one each for clinical research, clinical affairs, basic science research, for prevention and control research and for administration. The University and the Medical Center have made substantial commitments to the Cancer Center including the construction of a new $88 million facility to house the Center's outpatient clinics and research laboratories. The 285 Cancer Center members receive over $55 million in research and training support. In the nine years since its establishment the UMCCC has had a major impact on cancer research at the University of Michigan.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
3P30CA046592-11S3
Application #
2867530
Study Section
Cancer Centers and Research Programs Review Committee (CCRP)
Project Start
1988-09-30
Project End
2001-05-31
Budget Start
1998-06-01
Budget End
1999-05-31
Support Year
11
Fiscal Year
1998
Total Cost
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
791277940
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Hoban, Connor W; Beesley, Lauren J; Bellile, Emily L et al. (2018) Individualized outcome prognostication for patients with laryngeal cancer. Cancer 124:706-716
Maust, Joel D; Frankowski-McGregor, Christy L; Bankhead 3rd, Armand et al. (2018) Cyclooxygenase-2 Influences Response to Cotargeting of MEK and CDK4/6 in a Subpopulation of Pancreatic Cancers. Mol Cancer Ther 17:2495-2506
Arthur, Anna E; Goss, Amy M; Demark-Wahnefried, Wendy et al. (2018) Higher carbohydrate intake is associated with increased risk of all-cause and disease-specific mortality in head and neck cancer patients: results from a prospective cohort study. Int J Cancer 143:1105-1113
Valenciaga, Anisley; Saji, Motoyasu; Yu, Lianbo et al. (2018) Transcriptional targeting of oncogene addiction in medullary thyroid cancer. JCI Insight 3:
Akkina, Sarah R; Kim, Roderick Y; Stucken, Chaz L et al. (2018) Is There a Difference in Staging and Treatment of Head and Neck Squamous Cell Tumors Between Tertiary Care and Community-Based Institutions? Laryngoscope Investig Otolaryngol 3:290-295
Anwar, Talha; Arellano-Garcia, Caroline; Ropa, James et al. (2018) p38-mediated phosphorylation at T367 induces EZH2 cytoplasmic localization to promote breast cancer metastasis. Nat Commun 9:2801
Giraldez, Maria D; Spengler, Ryan M; Etheridge, Alton et al. (2018) Comprehensive multi-center assessment of small RNA-seq methods for quantitative miRNA profiling. Nat Biotechnol 36:746-757
Hartlerode, Andrea J; Regal, Joshua A; Ferguson, David O (2018) Reversible mislocalization of a disease-associated MRE11 splice variant product. Sci Rep 8:10121
Fritsche, Lars G; Gruber, Stephen B; Wu, Zhenke et al. (2018) Association of Polygenic Risk Scores for Multiple Cancers in a Phenome-wide Study: Results from The Michigan Genomics Initiative. Am J Hum Genet 102:1048-1061
Haley, Henry R; Shen, Nathan; Qyli, Tonela et al. (2018) Enhanced Bone Metastases in Skeletally Immature Mice. Tomography 4:84-93

Showing the most recent 10 out of 1493 publications